15 research outputs found

    Clinical characteristics and laboratory parameters of children with and without atherogenic dyslipidemia.

    No full text
    <p>BMI, body mass index; BP, blood pressure; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; ApoB, apolipoprotein B; ApoAI, apolipoprotein AI; hs-CRP, high sensitivity C Reactive Protein; HOMA-IR, homeostasis model assessment of IR index.</p><p>hs-CRP and adiponectin values are reported as median (interquartile range)</p><p>* p<0.05;</p><p>** p<0.01;</p><p>*** p<0.001</p><p>Clinical characteristics and laboratory parameters of children with and without atherogenic dyslipidemia.</p

    Clinical characteristics and laboratory parameters of parents and siblings of children with and without atherogenic dyslipidemia.

    No full text
    <p>BMI, body mass index; BP, blood pressure; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; ApoB, apolipoprotein B; ApoAI, apolipoprotein AI; hs-CRP, high sensitivity C Reactive Protein; HOMA-IR, homeostasis model assessment of IR index. hs-CRP and adiponectin values are reported as median (interquartile range)</p><p>* P<0.05;</p><p>** p<0.01;</p><p>*** p<0.001 between parents</p><p><sup><b>‡‡</b></sup> p<0.01;</p><p><sup><b>‡‡‡</b></sup> p<0.001 between siblings</p><p>Clinical characteristics and laboratory parameters of parents and siblings of children with and without atherogenic dyslipidemia.</p

    Prevalence in the cohort of probands with atherogenic dyslipidemia of non-synonymous exonic variants in the LPL gene.

    No full text
    <p><sup><b>a</b></sup>The name at protein level is without the pro-peptide.</p><p>n = number of variant alleles / number of total alleles</p><p><sup><b>b</b></sup>Frequency from database 1000 genomes EUR;</p><p><sup><b>c</b></sup>Frequency from ESP6500:European_American, the only available for L365V SNP.</p><p>Depending on the sample size and absolute frequencies in the contingency table:</p><p><sup><b>d</b></sup>Fisher exact test or</p><p><sup><b>e</b></sup>χ<sup>2</sup> was applied.</p><p><sup>#</sup> = annotations for the new variant are: NC_000008.11:g.19948306G>A; NG_008855.1:g.14236G>A; NM_000237.2:c.215G>A; NP_000228.1:p.Ser45Asn</p><p>* = statistically significant at indicated P level.</p><p>Prevalence in the cohort of probands with atherogenic dyslipidemia of non-synonymous exonic variants in the LPL gene.</p

    Distribution of SI values at different ages, stratified for genotypes and sex.

    No full text
    <p>SI values and their 95% confidence intervals at different ages for homozygotes of both <i>NMU</i> rs6827359 and <i>ADRB2</i> rs1042713 risk alleles (CC+GG, dark grey) and homozygotes for non-risk alleles (TT+AA, light gray) in subgroups of boys (panel A, n = 620, carriers of CC+GG = 101) and girls (panel B, n = 572, carriers of CC+GG = 85). Graph was obtained using SAS software (PROC SGPLOT with LOESS statement, see text). Local regression method implies that statistical power decreases at extreme <i>x</i> values (larger confidence intervals).</p
    corecore